This article needs more
reliable medical references for
verification or relies too heavily on
primary sources. (November 2023) |
Chalicosis | |
---|---|
Other names | Flint disease |
Specialty | Respirology |
Chalicosis is a form of pneumoconiosis affecting the lungs or bronchioles, found mainly among stonecutters. [1] The disease is caused by the inhalation of fine particles of stone. [2] The term is from Greek, χάλιξ, gravel.
Occupations with significant exposure to stone dust are at an increased risk of chalicosis include:
Signs and symptoms of chalicosis are slow to develop and thus patients may not show signs of incapacity until years after exposure. [4] It may even take up to 10 years before manifestations of the disorder are present. [3] Signs and symptoms include:
There is no definitive cure for chalicosis, [5] nor is there a specific targeted therapy. [3] Current treatment of this lung disorder primarily involves managing respiratory symptoms, associated comorbidities, and complications, with the overarching goal of enhancing the patient's quality of life. [5] [3] These include:
This article needs more
reliable medical references for
verification or relies too heavily on
primary sources. (November 2023) |
Chalicosis | |
---|---|
Other names | Flint disease |
Specialty | Respirology |
Chalicosis is a form of pneumoconiosis affecting the lungs or bronchioles, found mainly among stonecutters. [1] The disease is caused by the inhalation of fine particles of stone. [2] The term is from Greek, χάλιξ, gravel.
Occupations with significant exposure to stone dust are at an increased risk of chalicosis include:
Signs and symptoms of chalicosis are slow to develop and thus patients may not show signs of incapacity until years after exposure. [4] It may even take up to 10 years before manifestations of the disorder are present. [3] Signs and symptoms include:
There is no definitive cure for chalicosis, [5] nor is there a specific targeted therapy. [3] Current treatment of this lung disorder primarily involves managing respiratory symptoms, associated comorbidities, and complications, with the overarching goal of enhancing the patient's quality of life. [5] [3] These include: